A solid oxide fuel cell (SOFC) is a fuel cell that produces electricity through an electrochemical process. SOFCs offer low emissions, long-term stability, high efficiency, and fuel flexibility. The excellent fuel flexibility of the devices permits the use of safe, cheaper, and readily available hydrocarbons such as natural gas, methane, and syngas. SOFCs, however, function at a high operating temperature, usually within the range of 800°C-1000°C for the activation of the electrolyte, making them far less susceptible to carbon monoxide poisoning and thereby, longer lasting. Analysts forecast the global SOFC market to grow at a compound annual growth rate of 9.78 percent during the period from 2016-2020 (Estimated market value of $614.92 billion in 2015).

Dominovas Energy Corp. (OTCQB: DNRG) is an energy solutions company dedicated to delivering clean, efficient and reliable electricity to areas of the world that lack this precious commodity on a multi-megawatt scale. At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary ”disruptive technology” and energy solution powered by the RUBICON™ Series SOFC Technology.

Led by the incomparable scholar, professor, and visionary Dr. Shamiul Islam, the RUBICON™ is expected to achieve more than 50 percent fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in modular multi-megawatt power arrays. The proprietary system is also uniquely capable of reforming and converting multiple fuel stocks such as natural gas and bio-fuel, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

Renewable energy will represent the largest single source of electricity growth over the next five years, driven by falling costs and aggressive expansion in emerging economies, according to the International Energy Agency’s annual market report. The report sees the share of renewable energy in global power generation rising to over 26 percent by 2020 from 22 percent in 2013 – a remarkable shift in a very limited period of time. By 2020, the amount of global electricity generation coming from renewable energy will be higher than today’s combined electricity demand of China, India and Brazil.

The report says the geography of deployment will increasingly shift to frontier economies and developing countries, which will make up two-thirds of the renewable electricity expansion to 2020. China alone will account for nearly 40 percent of total renewable power capacity growth and requires almost one-third of new investment to 2020.

For more information, visit www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

Immune Therapeutics, Inc. (OTCQB: IMUN) made two additions to its board recently, and if experience and knowledge are said to be key indicators of effectiveness, employees and shareholders alike have reason to be elated with the news. Dr. Clifford A. Selsky and Paul Akin carry a wealth of experience in their respective areas of influence and bolster the company’s leadership assets going forward. Paul Akin brings financial experience developed across his prior operating and board roles to the IMUN board. Dr. Selsky offers a vital perspective as a scientist, physician and patient advocate. The company intends to use their respective know-how on its road toward pursuing financial growth while developing and commercializing novel, patented therapies for life-threatening diseases by activating the body’s immune system.

Noreen Griffin, CEO of Immune Therapeutics, noted in a press release, “Paul Akin and Dr. Selsky’s breadth of knowledge and experience will provide invaluable insight to Immune as we continue to grow the business and strive to deliver innovative therapies in emerging nations.”

Clifford A. Selsky, PhD, MD, has been a pediatrician for the past 20 years, earning his PhD in microbiology and molecular genetics at the University of Miami School of Medicine prior to completing DNA repair research studies at Harvard School of Public Health and Stanford University.

Paul Akin brings more than 25 years of leadership experience to IMUN’s board. Akin played an important role in the strategic planning and coordination of market penetration, capitalization and expansion. He currently serves as the CEO and executive chairman of San Francisco-based Collier Warehouse Group, where he’s fostered annual double-digit growth rates during his tenure.

Immune Therapeutics, Inc. is a biotechnology company with a leading portfolio of immunotherapy technologies aimed at capturing the promise of the immune system for improving the treatment of cancer, HIV/Aids and other chronic and autoimmune diseases. The company is currently looking into investigations of its programs for met-enkephalin (MENK) and low dose naltrexone (LDN), or Lodonal™ – as treatments for many underserved indications.

In February, leading independent equity research and corporate access firm SeeThruEquity announced that it has initiated coverage on Immune Therapeutics with a 12-month price target of $0.61.

Learn more by visiting www.immunetherapeutics.com

Let us hear your thoughts: Immune Therapeutics, Inc. Message Board

The Arizona-based junior exploration company, Star Mountain Resources, Inc. (OTC: SMRS), is only interested in acquiring high-potential mining resources that it will turn into producing assets. The company focuses on base and precious metals in North America and has operations in New York and Utah. Led by a knowledgeable management team, Star Mountain Resources can see potential where others may not. This vision has led the company on an upward journey of revenue increases and shareholder confidence through its Balmat mine acquisition.

The Balmat zinc mine in upstate New York shut down operations in 2008, but when companies approached its controlling company, Hudbay Minerals, for purchase, sales always seemed to fall through. Back then, zinc was not a “hot commodity” and was seen as a poor investment. However, in November 2015, Star Mountain Resources closed a deal with Hudbay Minerals and finally had the mine in its possession. The company’s chief operating officer, Mark Osterberg, stated at the time that, “The mining cycle is down, which means that assets like Balmat are available at bargain prices. So we think we bought the property at a very good price and we believe the commodity prices are going to come back up.”

Osterberg and Star Mountain Resources couldn’t have been more correct. Since January, zinc value has increased more than 20% from a six-year low. The deficit of 440,000 metric tons this year has caused prices to increase with demand. Furthermore, Goldman-Sachs has predicted 12-month zinc prices at $1,800 a ton. Star Mountain Resources recently reported that their mine has a reserve estimate of 585,000 tons of 9.2% grade zinc that could generate over $80 million over the course of 2.5 years. What was deemed a risky investment in 2008 now rewards a company that saw its future potential.

Spearheading Star Mountain Resources is an impressive, forward-thinking team consisting of CEO Joseph Marchal, COO Mark Osterberg, CFO Wayne Rich, VP Thomas Bidgood, operations manager John Heinzig, and site manager Ryan Schermerhorn. Plus, the company recruits local experts at each operation site to maintain strong community ties while gaining intuitive workers.

Through expert knowledge, due diligence, and experience, Star Mountain Resources chooses acquisitions that will become profitable for both shareholders and the company. The ability to foresee high-potential producing assets is a trait that marks a successful company.

For more information, visit www.starmountainresources.com

Let us hear your thoughts: Star Mountain Resources Inc. Message Board

A recent article in the Harvard Business Review (HBR), entitled The Sharing Economy Isn’t About Sharing at All, shows that FlexWeek, Inc.’s (OTC: FXWK) innovative online platform for travelshare rentals is an idea whose time has come. The FlexWeek platform ‘allows timeshare owners to discover, book and offer unused vacation time (travelshares) directly to the public and other timeshare owners.’ As the title of the HBR piece suggests, the label ‘sharing economy’ is misleading. The authors, two well-respected professors of marketing, go on to point out that the essential characteristic of the peer-to-peer (P2P) business model is access. That is an important insight and it’s one that drives FlexWeek’s strategy.

The rise of the peer-to-peer approach has given rise to a new range of businesses. An illuminating story (http://dtn.fm/0nLZ4) in Currency Fair, entitled The Peer-To-Peer Marketplace Revolution: 50+ Companies That Are Changing The World, names Craigslist, Uber, Zipcar, Kickstarter, Lending Club, and, of course, AirBnB. Peer-to-peer is a term borrowed from computer architecture vocabulary that was meant, initially, to indicate a contrast to centrally-controlled systems. Consequently, the early excitement with P2P models was their devolution of power, which was thought to translate into equality and freedom for the participating peers. Since the French Revolution, however, fraternity is never far away from liberty and equality. So early P2P endeavors with a strong flavor of communality and social interaction were an expected sine qua non.

Eckhardt and Bardhi take issue with this accepted rationale of the success of P2P nexus, doubting whether participants on such platforms are seeking brotherhood and social interaction. They rather believe companies that ‘emphasize convenience and price over the ability to foster connections will have a competitive advantage’. To illustrate this, they compare the two different approaches taken by Uber and Lyft. They endorse the privately-held Uber’s strategy that ‘positions itself squarely around its pricing, reliability, and convenience (that) is encapsulated in their tagline, “Better, faster and cheaper than a taxi.”’ However, they say a contributing reason that almost identical rival Lyft has not had Uber-rate growth is that its sales propositions, such as “We’re your friend with a car” and “Greet your driver with a fist bump,” are directed at our gregarious natures. Peer-to-peer business may involve some degree of winning friends, but when we call a cab, it’s not because we want to be chums with the cabbie.

The two professors confess dismay with AirBnB’s recent re-branding, which highlights ‘people, places, love and community’, saying “The reason why most consumers use AirBnB is the value they can get for their money.” A peer-to-peer commerce model is superior when it provides ‘convenient and cost-effective access to valued resources, flexibility, and freedom from the financial, social, and emotional obligations embedded in ownership and sharing’.

A Bloomberg piece (http://dtn.fm/dOXv6) that appears to have ingested Eckhardt and Bardhi’s main argument touts Uber as the poster child for the access economy with an estimated valuation ‘north of $50 billion’. The Bloomberg story also highlights AirBnB. It points out that the privately-held AirBnB is valued at around $25 billion and carries more than 1.5 million listings for accommodation in 34,000 cities around the world. FlexWeek aims to do for timeshares what AirBnB has done for the online marketplace that enables individuals to rent their rooms, apartments or houses to short-term guests.

FlexWeek’s P2P website (www.FlexWeek.com) and mobile application is similar to AirBNB’s $25 billion approach to the travel industry. (A December 2015 filing with the SEC in regard to funding of $1.5 billion values AirBnB at $25.5 billion) FlexWeek is the first and only P2P marketplace exclusive to fractional vacation ownerships. Its platform differs from the existing costly model under which timeshare weeks must be ‘banked’ with a trading company such as Interval International or RCI. Instead, the booking fees are charged to the renter of the travelshare or vacation time. FlexWeek is a pioneer in this Peer-to-Peer Travelshare market, and the FlexWeek engine is currently undergoing v2 Beta testing. FlexWeek also offers premium members a service through its wholly-owned subsidiary, Choice Journeys, which provides access to discounted timeshare inventory in addition to cruise and luxury vacation homes in the United States, Canada, Mexico, Caribbean, Europe and Asia.

FlexWeek’s prospects look good. Based on data in the recent State of the Vacation Timeshare Industry: United States Study 2015 Edition and other information supplied by the American Resort Development Association, the potential size of the re-sale and rental market is about $1.6 billion. AirBnb’s success shows that helping the world to travel on holiday is one road to success. That’s a road that FlexWeek, with its novel travelshare concept, is likely to pave anew.

For more information, visit www.flexweek.com

Let us hear your thoughts: FlexWeek, Inc. Message Board

Before the opening bell, International Stem Cell Corporation (OTCQB: ISCO) took a major step in the development of its human parthenogenetic stem cell-derived neural stem cells (ISC-hpNSC) for the treatment of moderate to severe Parkinson’s disease when it announced the commencement of enrollment for its upcoming phase I clinical trial. This announcement followed the Melbourne Health Human Research Ethics Committee’s (HREC) recent decision to grant approval of the phase I clinical trial in patients with moderate to severe Parkinson’s disease. The trial is scheduled to take place at the Royal Melbourne Hospital in Australia.

“Enrollment in this trial is an important milestone,” Dr. Russell Kern, executive vice president and chief scientific officer of ISCO, stated in this morning’s release. “Promising preclinical results support our expectation that ISC-hpNSC will bring a long-needed solution for patients suffering from Parkinson’s disease.”

Following completion of enrollment, ISCO will commence a dose escalation safety and preliminary efficacy study of its proprietary ISC-hpNSC. The clinical trial will involve intracranial transplantation of the stem cells into patients with moderate to severe Parkinson’s disease. A total of 12 patients are expected to participate in the trial, with three different dose regimens being studied. Following transplantation, the patients will be monitored at specified intervals for one year, with PET scans being performed as part of the screening assessment. The study’s submission will be overseen by Cyto Therapeutics Pty Ltd., a subsidiary of ISCO.

ISC-hpNSC have demonstrated promising results in preclinical studies. In both rodents and non-human primates, the highly pure stem cells have supported improvement in Parkinson’s symptoms and increases in brain dopamine levels. Additionally, ISC-hpNSC have been safe, well-tolerated and free from adverse side effects such as dyskinesia, systemic toxicity and tumors in preclinical models.

If approved, ISCO’s groundbreaking approach to the treatment of Parkinson’s disease could revolutionize an expansive treatment market. Currently, medications used to treat Parkinson’s, including L-DOPA and dopamine agonists, serve only to improve the early symptoms associated with the disease. As the illness progresses, the loss of dopaminergic neurons eventually renders these drugs ineffective while at the same time producing a complication marked by involuntary writhing movements. In recent years, incidence of Parkinson’s has been on the rise. In 2013, the disease resulted in roughly 103,000 deaths globally, up from about 44,000 deaths in 1990.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

Before the opening bell, Content Checked Holdings, Inc. (OTCQB: CNCK) announced a strategic partnership with leading New York City-based capital markets advisory firm PCG Advisory Group (PCG). Following this announcement, PCG is expected to serve as an advisor for the company’s ongoing investor relations, social media and public relations strategies.

“Our search for a partner with the capital markets expertise to communicate our story to both institutional and retail investors, while increasing our new media profile and social media engagement, resulted in the most obvious conclusion,” Kris Finstad, chief executive officer of Content Checked, stated in this morning’s news release. “Our engagement of PCG is reflective of their unique capability to provide valuable insight and exposure to our exciting products, partnerships and developing pipeline.”

The PCG partnership comes as Content Checked prepares to unveil an updated revenue strategy for its innovative suite of mobile apps. In January, the company outlined plans to shift toward a subscription-based revenue model for its apps in an attempt to capitalize on emerging mobile trends. Content Checked’s highly anticipated relaunch and rebranding of its products is expected to take place later this month.

“Content Checked’s intriguing formula of fusing cutting-edge technology with nutrition provides a compelling story to present to our investor community and network,” Jeff Ramson, founder and chief executive officer of PCG, stated in the release. “Their recent positive financial developments, partnerships and product milestones, illustrate a unique growth opportunity in an extremely relevant market with very optimistic long-term prospects.”

A product relaunch is expected to be the first in a series of moves designed to help Content Checked continue to diversify and grow in the thriving health and wellness space. In a letter to shareholders, Finstad outlined plans to extend the company’s brand in the months to come in an effort to add value to its current family of mobile apps. These efforts will likely play an instrumental role in Content Checked’s ongoing efforts to uplist to a major exchange – the NASDAQ or the NYSE – later this year.

Last month, the company took a major step toward achieving this goal when it announced a partnership with Kitchology, Inc. through which it opened a new revenue stream via the licensing of its nutritional data. Through this agreement, Content Checked granted Kitchology a limited, non-exclusive worldwide right to use, display and analyze data from the Content Checked database and present that information to users of the Kitchology platform.

For more information, visit www.contentchecked.com

Let us hear your thoughts: ContentChecked Holdings Inc. Message Board

A technology that dates back two millennia is behind OurPet’s Company’s (OTCQX: OPCO) new Switchgrass Biochar Litter. As Emily Wayne of Oxford University explains in Conquistadors, cannibals and climate change: A brief history of biochar (http://dtn.fm/A4Czi), “In 1870, James Orton, a little-known American geologist and explorer, noticed that alongside the typically grey, acidic soils of the (Amazon) basin there existed large patches of ‘black and very fertile’ soil… Researchers flocked to investigate the mysterious dark earth, or ‘terra preta’ as it is known locally.” On closer examination, the soil appeared to have been modified by early human settlers. It seems the early Amazonians had originated an organic method of fertilizing the soil. These terra preta plots date back to antiquity, the oldest site at 8,000 BCE. It all appeared to have started when these ancient peoples discovered that, by charring organic waste in ovens with a low-oxygen supply, a process known as pyrolysis, charcoal for use as a fuel could be produced. Somehow this carbon found its way into the soil, giving it a characteristically black color due to the high concentration of carbon. Terra preta contains up to 9 percent carbon, compared with 0.5 percent in surrounding soils.

At some point it was realized that such soil yielded more abundant crops for longer periods. Even with the use of chemical fertilizers, crop yields will fall off rapidly after a third consecutive growing season, yet the terra preta soil has retained its fertility for centuries. So, naturally, efforts were made to reproduce the ancient techniques of terra preta production. This has given birth to biological charcoal (biochar), which can be defined simply as charcoal used for agricultural purposes.

Charcoal is able to remove odors very effectively because a quantity of charcoal absorbs many times its volume of noxious gases. Charcoal is a porous form of carbon and so has a very large ‘surface area’ which enhances its powers of absorption. It does a great job of absorbing the ‘rotten egg’ odor that cat waste gives off. This rotten egg gas is actually hydrogen sulfide (H2S), a poisonous, highly flammable, colorless gas that, in high enough concentrations, can cause loss of consciousness. An old story (http://dtn.fm/94Bsh) in Sky News told how a vet in Sweden was hospitalized for three days after being exposed to 20 flatulent cats.

OurPet’s Company continues to demonstrate its technological prowess with Switchgrass Biochar Litter. The company’s CEO, Dr. Steven Tsengas, is an engineer and inventor who has been elected to the National Inventors Hall of Fame. OurPet’s Company’s engineering expertise and open approach to new ideas has been employed, over the years, to develop the company’s portfolio of over 1,000 products. The company also has another 30 or so products in the pipeline and an intellectual property stockpile of over 160 patents. Recently, OurPet’s Company announced a new strategic partnership with the Japanese software developer, Aplix IP Holdings Corporation, a company known for its WirelessIDEA software-based technology for machine to machine (M2M) applications and its JBlend, a Java Micro Edition (Java ME) platform for embedded software, which has been installed in close to three-quarters of a billion devices worldwide.

In a recent earnings release, Dr. Tsengas said, “We remain focused on growth initiatives in all three of our key product categories; feeding and storage, toys and accessories, and waste management and odor control.’. Those of us with hyperosmia are happy to hear that.

For more information, visit the company’s website at www.ourpets.com

Let us hear your thoughts: OurPet’s Co. Message Board

Unimpeded opportunity for all Americans is essential to our economic and political prosperity. To retain hegemony in bringing new products and services to the marketplace both in the U.S. and abroad, franchise systems continue to provide the widest possible entrepreneurial opportunities for everyone. Los Angeles-based Giggles N’ Hugs, Inc. (OTCQB: GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic, gourmet food and exciting play elements for children, with a 2,500-square-foot play space in the middle of its restaurants.

The concept is similar to Chuck E. Cheese, but offers a healthier, high-end version for health conscious parents and families. Parents eat and relax, while the kids have an incredible time playing in the custom-made play area, which is loaded with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.

Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40 percent), admission and membership fees, and retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in some of the premier malls around Los Angeles, and four of the largest mall owners in the country have offered Giggles N’ Hugs up to 75 percent discounts on rent and upward of $700,000 of upfront cash for each location in order to get Giggles N’ Hugs into their properties located around the country.

In other words, the proof is in the ‘organic bread pudding’ with the concept Giggles N’ Hugs has created. The company has taken a successful business model (i.e. Chuck E. Cheese) and adapted it to today’s health conscience consumer with its organic menu items. It’s essential to appeal to as many audiences as possible when providing products and services. Giggles N’ Hugs has forged a perfect marriage, so to speak, with its ‘kid friendly’ birthday party atmosphere and delicious menu, allowing it to appeal to nearly every demographic.

Learn more by visiting www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

Propanc Health Group Corp. (OTCQB: PPCH) is an emerging healthcare company focused on the development of new and proprietary treatments for cancer patients suffering from solid tumors, such as those resulting from pancreatic, ovarian, and colorectal cancers. The company recently announced results from studies for its lead product, PRP, confirming a synergistic response to a broad range of cancer indications, including kidney, melanoma, brain, prostate, liver, uterine and lung cancers. The data provides compelling evidence that PRP has the potential to fight a broad range of cancer types, some with significant unmet medical needs. The company will continue to investigate PRP’s efficacy in these indications through clinical trials.

Moreover, data from the recent cell line studies tested at the R&D facility of Propanc’s contract research partner, vivoPharm LLC, which is headquartered in Hershey, Pennsylvania, showed a synergistic response between the two active components, trypsinogen and chymotrypsinogen, further strengthening its lead patent claims in key jurisdictions throughout North America and Europe.

The company has also confirmed a scientific advice meeting with the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom, currently scheduled for the end of April. The purpose of the meeting is to discuss Propanc’s ongoing development activities for PRP, including preparation and structure of animal safety/toxicology studies and its proposed early stage patient trials, together with supporting activities.

Propanc has developed a formulation of anti-cancer compounds which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Its products involve or employ proenzymes, which are inactive precursors of enzymes.

Learn more by visiting www.propanc.com

Oakridge Global Energy Solutions, Inc. (OTCQB: OGES) scored a birdie at the recent Orlando PGA Merchandise Show, which came to a close on January 29, 2016. The company received orders of more than $250,000 and follow on commitments exceeding $20,575,000 for its Pro Series Lithium Ion Golf Car battery systems. These large format golf cart batteries were launched at this same Professional Golfers’ Association (PGA) show in Orlando, Florida, back in January 2015. No doubt, the size of Oakridge’s order book is a sign of things to come in the lithium industry.

A research report published by Goldman Sachs in December 2015, titled ‘What if I Told you… Themes, Dreams and Flying Machines’, proclaims ‘Lithium is the new gasoline’. The report states that the confluence of technological innovation, government support and public embrace of green technologies will increase electric vehicle (EV) penetration from three percent now to 22 percent in 10 years’ time. The automotive industry will, undoubtedly, have its eyes on companies like Oakridge to see how the Pro Series performs, because the golf carts it will power may be considered a type of battery electric vehicle (BEV), like the Nissan (OTC: NSANY) Leaf, the Fiat (NYSE: FCAU) 500e or the Tesla (NASDAQ: TSLA) Model S. This market development in EVs is expected to invigorate the entire lithium industry.

The Goldman Sachs analysts are not the only ones that see upbeat prospects for lithium. The industry analysts at Japanese research firm Taiyou Research surmise that ‘the global market for lithium ion batteries is a fast growing one and is expected to cross $30 billion by 2020’. At present, lithium ion batteries are mostly found in consumer electronic devices, but with the advent of cells of greater capacity and power in large-format applications, their use in EVs and storage applications is increasing. Both capacity and power are important factors in batteries and, depending on the application, one takes precedence to the other. These characteristics can be examined by comparing them to containers. A 2-liter bottle has a large volume and a small mouth, similar to a high-energy low-power system. A 1 lb. marmalade jar, on the other hand, has small volume but a large mouth, similar to a low-energy high-power system.

Oakridge manufactures both high-energy low-power systems and low-energy high-power systems. Its Pro Series, which has been such a big hit at the PGA show, is a high-energy low-power battery. The Pro Series comes in four capacities, measured in ampere-hours (Ah) – including 40 Ah, 60 Ah, 100 Ah and 160 Ah – all of which have a recommended voltage limit for discharge of 12 volts. At that discharge rate, the Pro Series 40Ah is expected to provide energy enough for at least 20 miles. The Pro Series 60Ah will provide enough energy for 30 miles; the Pro Series 100Ah will reach 55 miles; and the Pro Series 160Ah will get to 90 miles or more. The Pro Series is designed to be a good caddy, giving you 12 to 16 rounds per charge.

Oakridge Global Energy Solutions is holding the course with pro golfers, and now it’s planning on joining the easy riders. A commercial introduction of the Liberty Series Lithium Ion motorcycle battery is planned for the 75th anniversary of the Daytona Beach Bike Week, which runs from March 4 – 13, 2016. Oakridge’s Liberty Series is an example of a low-energy high-power battery that is required in starting, lighting and ignition (SLI) systems.

For more information, visit www.oakridgeglobalenergy.com

Let us hear your thoughts: Oakridge Global Energy Solutions, Inc. Message Board